u/Responsible-Quote717

"Now, the biotech—formerly known as MindMed—plans to share anxiety data this week, findings that could push Definium’s stock up “25-50% or more,” Jefferies analysts wrote in a Thursday note."

🤑🚀

With the GAD results due this week, I assume we're all expecting similar results to what we got with the Phase 2b trial and the MDD results from June.

But, how priced-in do you think these results are already? What sort of price movement are we expecting after the results drop? Any guesses?

Good luck and Godspeed. 🚀

Most of the research on LSD focuses on the experience itself: what people see, feel, and think while the drug is active. The hours during the trip are treated as the event. What comes after is treated as the aftermath, a return to normal.

A new study from the University of Fribourg asked a different question. Instead of measuring what LSD does while people are on it, researchers waited. They gave 45 healthy adults a full clinical dose and sent them home. They did not test them that day.

One week later, participants came back. The researchers measured their stress levels using validated psychological scales. They measured their ability to generate alternative solutions to difficult problems, a core component of cognitive flexibility. They ran motor learning tests. They took brain measurements.

What they found in that one-week window was not what most people would expect from a drug that had finished working six days earlier.

There's been a lot of comments about profit selling, but who out there is buying at the moment?

If you're planning on buying more in the future, what sort of pullback are you looking for as an entry point?

So, are we all thinking that June 11th is the date we get out first Phase III results announcement?

Is this the week we've been waiting for for years?

Will we be above $30 by weeks end?

How are we all feeling?